Crunching the numbers for XYL... Refresh in a moment for the full analysis.
Xylem Inc. (XYL)
Technology
Deep Overvalued
healthy
$128.72
Updated: 2026-04-12
60
TradeApes Score
add
Financial Strength
70
Healthy
Operating Trend
50
Mixed
Valuation
60
Healthy
Capital Allocation
55
Mixed
Risk
70
Healthy
Fair Value
$58.87
DCF Upside
-54.3%
Sector Rank
#24
of 58
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
High P/E — 25–45×, growth premium already priced in
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.